Complexes of factor VII-activating protease with plasminogen activator inhibitor-1 in human sepsis

Femke Stephan; Ingrid Bulder; Brenda M. Luken; Jan Hazelzet; Walter A. Wuillemin; Sacha Zeerleder

doi:10.1160/TH13-12-1062

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 112(01): 219-221
DOI: 10.1160/TH13-12-1062

Letters to the Editor

Schattauer GmbH

Complexes of factor VII-activating protease with plasminogen activator inhibitor-1 in human sepsis

Femke Stephan

¹Department of Immunopathology, Sanquin Blood Supply and Landsteiner Laboratory of the AMC, Amsterdam, The Netherlands

,

Ingrid Bulder

¹Department of Immunopathology, Sanquin Blood Supply and Landsteiner Laboratory of the AMC, Amsterdam, The Netherlands

,

Brenda M. Luken

¹Department of Immunopathology, Sanquin Blood Supply and Landsteiner Laboratory of the AMC, Amsterdam, The Netherlands

,

Jan Hazelzet

²Department of Pediatrics, Division of Pediatric Intensive Care, Erasmus MC – Sophia Children’s Hospital, Rotterdam, The Netherlands

,

Walter A. Wuillemin

³Division of Hematology and Central Laboratory of Hematology, Luzerner Kantonsspital, University of Berne, Lucerne, Switzerland

,

Sacha Zeerleder

¹Department of Immunopathology, Sanquin Blood Supply and Landsteiner Laboratory of the AMC, Amsterdam, The Netherlands

⁴Department of Hematology, Academic Medical Center, University of Amsterdam, The Netherlands

› Author Affiliations

Abstract

Full Text

References

References
1 Hotchkiss RS, Nicholson DW. Apoptosis and cas-pases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 06: 813-822.
2 Xu J, Zhang X, Pelayo R. et al. Extracellular hi-stones are major mediators of death in sepsis. Nat Med 2009; 15: 1318-1321.
3 van Till JW, van Veen SQ, den Broeder V. et al. Compartmental apoptosis and neutrophil accumulation in severe peritonitis. J Surg Res 2010; 164: 321-328.
4 Zeerleder S, Zwart B, Wuillemin WA. et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003; 31: 1947-1951.
5 Zeerleder S, Stephan F, Emonts M. et al. Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C. Crit Care Med 2012; 40: 3224-3229.
6 Zeerleder S, Zwart B, te Velthuis H. et al. Nucleo-some-releasing factor: a new role for factor VII-ac-tivating protease (FSAP). FASEB J 2008; 22: 4077-4084.
7 Etscheid M, Beer N, Fink E. et al. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin. Biol Chem 2002; 383: 1633-1643.
8 Etscheid M, Hunfeld A, Konig H. et al. Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism. Biol Chem 2000; 381: 1223-1231.
9 Stephan F, Hazelzet JA, Bulder I. et al. Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit Care 2011; 15: R110.
10 Wygrecka M, Morty RE, Markart P. et al. Plasmi-nogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome. J Biol Chem 2007; 282: 21671-21682.
11 Pralong G, Calandra T, Glauser MP. et al. Plasmi-nogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 1989; 61: 459-462.
12 Brandtzaeg P, Joo GB, Brusletto B. et al. Plasmi-nogen activator inhibitor 1 and 2, alpha-2-anti-plasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 1990; 57: 271-278.
13 Hermans PW, Hibberd ML, Booy R. et al. 4G/5G promoter polymorphism in the plasminogen-acti-vator-inhibitor-1 gene and outcome of mening-ococcal disease Meningococcal Research Group. Lancet 1999; 354: 556-560.
14 Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest 2005; 128: 2864-2875.
15 de Boer JP, Abbink JJ, Brouwer MC. et al. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1991; 65: 181-185.
16 Gils A, Declerck PJ. Proteinase specificity and functional diversity in point mutants of plasmi-nogen activator inhibitor 1. J Biol Chem 1997; 272: 12662-12666.
17 ACCP Sccc. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992 101. 1644-1655.
18 de Kleijn ED, de Groot R, Hack CE. et al. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003; 31: 1839-1847.
19 Yamamichi S, Fujiwara Y, Kikuchi T. et al. Extracellular histone induces plasma hyaluronan-bind-ing protein (factor VII activating protease) activation in vivo. Biochem Biophys Res Commun 2011; 409: 483-488.
20 Silverman GA, Bird PI, Carrell RW. et al. The ser-pins are an expanding superfamily of structurally similar but functionally diverse proteins Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001; 276: 33293-33296.
21 Biemond BJ, Levi M, Ten Cate H. et al. Plasmi-nogen activator and plasminogen activator inhibitor I release during experimental endotoxae-mia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci 1995; 88: 587-594.
22 Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF. et al. Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromb Haemost 1996; 76: 932-938.
23 Mesters RM, Florke N, Ostermann H. et al. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemost 1996; 75: 902-907.